| 08:30 | P1618 | A polymethoxy flavonoid, Nobiletin, Has a therapeutic potency against the development of heart failure through NBP1 activation. | Yoichi SUNAGAWA (Shizuoka, Japan) |
|
| 08:30 | P1619 | Polymorphic variants rs6684209 and rs7521023 of the calsequestrin 2 gene as risk factors for adverse course of heart failure | Elvira MUSLIMOVA (Tomsk, Russian Federation) |
|
| 08:30 | P1620 | Association of granulocyte neprilysin (CD10) expression with prognosis in heart failure with reduced ejection fraction | Henrike ARFSTEN (Vienna, Austria) |
|
| 08:30 | P1621 | m6A RNA-methylation in the progression of heart failure | Eric BUCHHOLZ (Goettingen, Germany) |
|
| 08:30 | P1622 | Cancer drugs induce functional and structural impairment in adult cardiomyocytes. | Claudia ALTOMARE (Taverne-Torricella, Switzerland) |
|
| 08:30 | P1623 | Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice | Yoshikuni OBATA (Sapporo, Japan) |
|
| 08:30 | P1624 | Blockade of protease activated receptor-1 signaling attenuates cardiac hypertrophy and fibrosis in renin-overexpressing hypertensive mice | Yoshikazu YOKONO (Hirosaki, Japan) |
|
| 08:30 | P1625 | A pivotal role for cytotoxic CD8+ T cells in development of cardiac fibrosis | Tin KYAW (Clayton South, Australia) |
|
| 08:30 | P1626 | MicroRNA-21 deteriorates left ventricular reverse remodeling by promoting cardiac fibrosis in non-ischemic cardiomyopathy | Ken WATANABE (Yamagata, Japan) |
|
| 08:30 | P1627 | Increased pericardial fibrosis and cardiac dysfunction in smooth muscle cell-specific SOCS3 deficient mice | Toshiyuki YANAI (, Japan) |
|
| 08:30 | P1628 | Angiopoietin-like protein (Angptl) 2 secreted from epicardial adipose tissue induces atrial myocardial fibrosis | Shintaro KIRA (Oita, Japan) |
|
| 08:30 | P1629 | Crispr/Cas9 to elucidate cardiac specific effects of Gdf11 | Luca CAMPARINI (, Italy) |
|